Global Intrauterine Devices Market Trends, Size, By Type (Nonhormonal: Copper-containing IUD, and Hormonal: Progestogen-releasing IUD), By Age Group (15-24 years, 25-34 years, 35-44 years, and Above 44 years), By End User (Hospitals, Clinics, Community Health Care Centres, and Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa): Global Opportunity Analysis and Industry Forecast, 2023-2030.
Global Intrauterine Contraceptive Devices (IUD) Market 
The Global Intrauterine Contraceptive Devices (IUD) Market was valued at US$ 4.35 Bn in 2022, estimated to reach US$ 3.78 Bn by 2030, with a CAGR of 6.34% from 2023-2030.
Small T-shaped devices called intrauterine devices (IUDs) are implanted in women's uteruses to stop pregnancy. Hormonal contraceptives, such as copper IUDs, are very popular. The market for intrauterine contraceptives is growing due to the products' many positive attributes. Government programs that emphasize the benefits of using IUDs have a significant impact on market demand. Even in developing countries, the need for these tools is the only reason for spreading the word about them. Intrauterine contraceptive devices are experiencing rapid market growth due to increasing demand and continuous innovation's stimulating effect.
Market Drivers
The global market is driven by an increase in awareness of Intrauterine Contraceptive Devices (IUD) availability due to campaigns and digital advertisements. Intrauterine devices (IUDs), which are tiny T-shaped devices, are placed in women's uteruses to prevent pregnancy. Popular hormonal contraceptives include copper IUDs. Because of the numerous advantages of the products, the intrauterine contraceptive industry is expanding. 
In addition, government initiatives that highlight the advantages of adopting IUDs have a big impact on consumer demand which is estimated to boost the market growth in the coming years. The sole justification for disseminating information about these instruments, even in underdeveloped nations, is their necessity. The market for intrauterine contraceptive devices is expanding quickly as a result of rising demand and the stimulating impact of ongoing innovation.
Market Restraints
The prevalence of dangers associated with intrauterine contraceptive devices, including infections, uterine damage, and excruciating cramping, among others, is anticipated to restrain market expansion. Additionally, the market for intrauterine contraceptive devices is anticipated to face challenges from strict regulations and reimbursement policies throughout the forecast period.
COVID 19 Impact
The COVID-19 pandemic had an effect on the health systems all over the world, interrupting access to services and information for family planning as well as the market for intrauterine contraceptive devices. Despite this disturbance, family planning is still necessary because it is an essential component of women's health care. Governments were collaborating with international organisations to make sure family planning remained a top priority for the world's health throughout and after the pandemic.
Market Segmentation
The scope of the Global Intrauterine Devices Market covers segmentation based on Product Consulting Product, Disease, Technology, and Region.
Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, and Hormonal: Progestogen-releasing IUD.
Based on Age Group, the market is classified into 15-24 years, 25-34 years, 35-44 years, and Above 44 years.
Based on End User, the market is divided into Hospitals, Clinics, Community Health Care Centres, and Others.
Regional Analysis
The Global Intrauterine Devices Market is segmented into 5 main regions, namely North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America estimated to hold major market share in the coming years. The market in the United States has demonstrated the highest demand for both hormone-based IUDs and copper that does not include hormones. For instance, it was predicted that 62 million American women used contraceptives between the ages of 15 and 44, according to a research report titled "Contraceptive Use in the United States" that was published in 2018. About 43 million of them were found to be at risk of unintended pregnancy, meaning that they are sexually active but do not want to get pregnant. However, the article warns that if they and their partners don't utilise a contraceptive technique appropriately and consistently, they might become pregnant.
Key Players
Bayer AG, CooperSurgical Inc, DKT International, Mona Lisa NV, Pregna International Limited, Prosan International BV, Abviee Inc, Eurogine, S.L., Viatris Inc, Mona Lisa N.V.
LevoCept, a long-acting reversible intrauterine system, will be the subject of a phase III clinical trial in June 2021 by Sebela Pharmaceuticals Inc. and PRA Health Sciences to evaluate its effectiveness, safety, and tolerability as a contraceptive. 
Market Taxonomy
By Type
Nonhormonal: Copper-containing IUD
Hormonal: Progestogen-releasing IUD
By Age Group
15-24 years
25-34 years
35-44 years
Above 44 years
By End User
Hospitals
Clinics
Community Health Care Centres
Others

Global Intrauterine Devices Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Intrauterine Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn.
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Intrauterine Devices Market, By Type
5.1 Y-o-Y Growth Comparison, By Age Group and Services
5.2 Global Intrauterine Devices Market Share Analysis, By Type
5.3 Global Intrauterine Devices Market Size and Forecast, By Type
5.3.1 Nonhormonal: Copper-containing IUD
5.3.2 Hormonal: Progestogen-releasing IUD
6 Global Intrauterine Devices Market, By Age Group
6.1 Y-o-Y Growth Comparison, By Age Group
6.2 Global Intrauterine Devices Market Share Analysis, By Age Group
6.3 Global Intrauterine Devices Market Size and Forecast, By Age Group 
6.3.1 15-24 years 
6.3.2 25-34 years
6.3.3 35-44 years
6.3.4 Above 44 years
7 Global Intrauterine Devices Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Intrauterine Devices Market Share Analysis, By End User
7.3 Global Intrauterine Devices Market Size and Forecast, By End User
7.3.1 Hospitals, Clinics
7.3.2 Clinics
7.3.3 Community Health Care Centres
7.3.4 Others
8 Global Intrauterine Devices Market, By Region
8.1 Global Intrauterine Devices Market Share Analysis, By Region
8.2 Global Intrauterine Devices Market Size and Forecast, By Region
8.3 Global Intrauterine Devices Market Trends and Forecast, By Region
9 North America Intrauterine Devices Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Intrauterine Devices Market Share Analysis, By Type
9.3 North America Intrauterine Devices Market Size and Forecast, By Age Group 
9.4 North America Intrauterine Devices Market Size and Forecast, By End User
9.5 North America Intrauterine Devices Market Size and Forecast, By Country
9.5.1 U.S.
9.5.1.1 Market Size and Forecast, By Type
9.5.1.2 Market Size and Forecast, By Age Group
9.5.1.3 Market Size and Forecast, By End User
9.5.2 Canada
9.5.2.1 Market Size and Forecast, By Type
9.5.2.2 Market Size and Forecast, By Age Group
9.5.2.3 Market Size and Forecast, By End User
9.5.3 Mexico
9.5.3.1 Market Size and Forecast, By Type
9.5.3.2 Market Size and Forecast, By Age Group
9.5.3.3 Market Size and Forecast, By End User
10 Europe Intrauterine Devices Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Intrauterine Devices Market Share Analysis, By Type
10.3 Europe Intrauterine Devices Market Size and Forecast, By Age Group 
10.4 Europe Intrauterine Devices Market Size and Forecast, By End User
10.5 Europe Intrauterine Devices Market Size and Forecast, By Country
10.5.1 Germany
10.5.1.1 Market Size and Forecast, By Type
10.5.1.2 Market Size and Forecast, By Age Group
10.5.1.3 Market Size and Forecast, By End User
10.5.2 France
10.5.2.1 Market Size and Forecast, By Type
10.5.2.2 Market Size and Forecast, By Age Group
10.5.2.3 Market Size and Forecast, By End User
10.5.3 UK
10.5.3.1 Market Size and Forecast, By Type
10.5.3.2 Market Size and Forecast, By Age Group
10.5.3.3 Market Size and Forecast, By End User
10.5.4. Russia 
10.5.4.1 Market Size and Forecast, By Type
10.5.4.2 Market Size and Forecast, By Age Group
10.5.4.3 Market Size and Forecast, By End User
10.5.5. Italy
10.5.5.1 Market Size and Forecast, By Type
10.5.5.2 Market Size and Forecast, By Age Group
10.5.5.3 Market Size and Forecast, By End User
10.5.6 Spain
10.5.6.1 Market Size and Forecast, By Type
10.5.6.2 Market Size and Forecast, By Age Group
10.5.6.3 Market Size and Forecast, By End User
10.5.7 Rest of Europe
10.5.7.1 Market Size and Forecast, By Type
10.5.7.2 Market Size and Forecast, By Age Group
10.5.7.3 Market Size and Forecast, By End User
11 Asia Pacific Intrauterine Devices Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Intrauterine Devices Market Share Analysis, By Type
11.3 Asia Pacific Intrauterine Devices Market Size and Forecast, By Age Group 
11.4 Asia Pacific Intrauterine Devices Market Size and Forecast, By End User
11.5 Asia Pacific Intrauterine Devices Market Size and Forecast, By Country
11.5.1 China
11.5.1.1 Market Size and Forecast, By Type
11.5.1.2 Market Size and Forecast, By Age Group
11.5.1.3 Market Size and Forecast, By End User
11.5.2 Japan
11.5.2.1 Market Size and Forecast, By Type
11.5.2.2 Market Size and Forecast, By Age Group
11.5.2.3 Market Size and Forecast, By End User
11.5.3 India
11.5.3.1 Market Size and Forecast, By Type
11.5.3.2 Market Size and Forecast, By Age Group
11.5.3.3 Market Size and Forecast, By End User
11.5.4. South Korea
11.5.4.1 Market Size and Forecast, By Type
11.5.4.2 Market Size and Forecast, By Age Group
11.5.4.3 Market Size and Forecast, By End User
11.5.5. Australia
11.5.5.1 Market Size and Forecast, By Type 
11.5.5.2 Market Size and Forecast, By Age Group
11.5.5.3 Market Size and Forecast, By End User
11.5.6. New Zealand
11.5.6.1 Market Size and Forecast, By Type
11.5.6.2 Market Size and Forecast, By Age Group
11.5.6.3 Market Size and Forecast, By End User
11.5.7 Singapore
11.5.7.1 Market Size and Forecast, By Type
11.5.7.2 Market Size and Forecast, By Age Group
11.5.7.3 Market Size and Forecast, By End User
11.5.8. Malaysia
11.5.8.1 Market Size and Forecast, By Age Group and Services
11.5.8.2 Market Size and Forecast, By Age Group
11.5.8.3 Market Size and Forecast, By End User
11.5.9 Rest of Asia
11.5.9.1 Market Size and Forecast, By Type
11.5.9.2 Market Size and Forecast, By Age Group
11.5.9.3 Market Size and Forecast, By End User
12 Latin America Intrauterine Devices Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Intrauterine Devices Market Share Analysis, By Type
12.3 Latin America Intrauterine Devices Market Size and Forecast, By Age Group 
12.4 Latin America Intrauterine Devices Market Size and Forecast, By End User
12.5 Latin America Intrauterine Devices Market Size and Forecast, By Country
12.5.1 Brazil
12.5.1.1 Market Size and Forecast, By Type
12.5.1.2 Market Size and Forecast, By Age Group
12.5.1.3 Market Size and Forecast, By End User
12.5.2 Argentina
12.5.2.1 Market Size and Forecast, By Type
12.5.2.2 Market Size and Forecast, By Age Group
12.5.2.3 Market Size and Forecast, By End User
12.5.3. Colombia
12.5.3.1 Market Size and Forecast, By Type
12.5.3.2 Market Size and Forecast, By Age Group
12.5.3.3 Market Size and Forecast, By End User
12.5.4. Peru
12.5.4.1 Market Size and Forecast, By Type
12.5.4.2 Market Size and Forecast, By Age Group
12.5.4.3 Market Size and Forecast, By End User
12.5.5 Chile
12.5.5.1 Market Size and Forecast, By Type
12.5.5.2 Market Size and Forecast, By Age Group
12.5.5.3 Market Size and Forecast, By End User
12.5.6 Venezuela
12.5.6.1 Market Size and Forecast, By Type
12.5.6.2 Market Size and Forecast, By Age Group
12.5.6.3 Market Size and Forecast, By End User
12.5.7 Rest of Latin America
12.5.7.1 Market Size and Forecast, By Type
12.5.7.2 Market Size and Forecast, By Age Group
12.5.7.3 Market Size and Forecast, By End User
13 Middle East Intrauterine Devices Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Intrauterine Devices Market Share Analysis, By Type
13.3 Middle East Intrauterine Devices Market Size and Forecast, By Age Group 
13.4 Middle East Intrauterine Devices Market Size and Forecast, By End User
13.5 Middle East Intrauterine Devices Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.1.1 Market Size and Forecast, By Type
13.5.1.2 Market Size and Forecast, By Age Group
13.5.1.3 Market Size and Forecast, By End User
13.5.2 UAE
13.5.2.1 Market Size and Forecast, By Type
13.5.2.2 Market Size and Forecast, By Age Group
13.5.2.3 Market Size and Forecast, By End User
13.5.3 Egypt
13.5.3.1 Market Size and Forecast, By Type
13.5.3.2 Market Size and Forecast, By Age Group
13.5.3.3 Market Size and Forecast, By End User
13.5.4 Kuwait
13.5.4.1 Market Size and Forecast, By Type
13.5.4.2 Market Size and Forecast, By Age Group
13.5.4.3 Market Size and Forecast, By End User
13.5.5 South Africa
13.5.5.1 Market Size and Forecast, By Type
13.5.5.2 Market Size and Forecast, By Age Group
13.5.5.3 Market Size and Forecast, By End User
13.5.5 Rest of Middle East & Africa
13.5.6.1 Market Size and Forecast, By Type
13.5.6.2 Market Size and Forecast, By Age Group
13.5.6.3 Market Size and Forecast, By End User
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Bayer AG
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 CooperSurgical Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 DKT International 
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Mona Lisa NV
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Pregna International Limited
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Prosan International BV
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Abviee Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Eurogine, S.L.
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Viatris Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Mona Lisa N.V.
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies